Bogart Wealth’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.2K Buy
69
+6
+10% +$1.19K ﹤0.01% 913
2026
Q2
$11.8K Buy
63
+53
+530% +$7.74K ﹤0.01% 949
2026
Q1
$973 Buy
+10
New +$1.01K ﹤0.01% 1455

Other funds holding RVMD

Bogart Wealth's RVMD Position: Q3 2026 in Review

Bogart Wealth increased its Revolution Medicines (RVMD) stake by 9.5% in Q3 2026, buying an estimated $1.19K and bringing the position to 69 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #913.

Bogart Wealth first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. 760 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Bogart Wealth held 69 shares of Revolution Medicines worth $14.2K as of Q3 2026.
  • Bogart Wealth bought 6 Revolution Medicines shares in Q3 2026, an estimated $1.19K.
  • Revolution Medicines made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #913 holding.
  • Bogart Wealth first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
  • 760 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.